Press Releases from vasopharm GmbH (1 total)
vasopharm Closes Series F Financing Round
- Company receives additional €5 million for preparation of Phase III study -
Wuerzburg, Germany; June 24, 2013 – vasopharm GmbH, a privately held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebro- and cardiovascular diseases, today announced the successful completion of a Series F financing round totalling €5 million (~ US$6.5 million). The round was led by existing investors HeidelbergCapital Private Equity and Entrepreneurs Fund (EF Investments S.à.r.l.).…
